By BY PAM BELLUCK from NYT Health Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many cases were asymptomatic. https://ift.tt/30M07J8
22 Kasım 2021 Pazartesi
Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug
By BY PAM BELLUCK from NYT Health Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many cases were asymptomatic. https://ift.tt/30M07J8
Kaydol:
Kayıt Yorumları (Atom)
Routine Childhood Vaccinations in the U.S. Slipped During the Pandemic
By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...
-
By BY EMILY ANTHES from NYT Health The F.D.A. authorized a breath-based test made by a small Texas company, which said it hoped that mobile...
-
By BY CARL ZIMMER from NYT Health https://ift.tt/2IHUMZY
-
https://ift.tt/2qR64Cz
Hiç yorum yok:
Yorum Gönder